Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial | Scientific Reports
Mean direct medical cost (€) per patient receiving exenatide bid or... | Download Table
Simulated progression of HbA1c in exenatide BID þ OAD (treatment arm)... | Download Scientific Diagram
Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes - Watanabe - 2020 - Journal of Diabetes Investigation - Wiley Online Library
Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin- exenatide study | BMC
Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metform
Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes - Wysham - 2018 - Diabetes, Obesity and Metabolism - Wiley Online Library
![exenatide [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c "exenatide [TUSOM | Pharmwiki]")
exenatide [TUSOM | Pharmwiki]
Liraglutide Versus Exenatide Once Weekly_ Persistence, Adherence, and Early Discontinuation
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - ScienceDirect
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial | Nature Communications
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Cla
Glycaemic control and hypoglycaemia in metformin-treated T2DM patients with exenatide BID vs insulin lispro TID added to titrated insulin glargine QD: the 4B trial - Media Centre | EASD
Exenatide - wikidoc
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes | Cardiovascular Diabetology | Full Text
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - ScienceDirect
Liraglutide Achieves A1C Targets More often than Sitagliptin or Exenatide when Added to Metformin in Patients with Type 2 Diabetes and a Baseline A1C <8.0% - Endocrine Practice
Abstract 13242: Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated With Exenatide BID or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLinkTM Database | Circulation
MTF Formulary Management for the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs)
Abstract 13242: Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated With Exenatide BID or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLinkTM Database | Circulation
Table 2 from Exenatide ( Byetta ) , an Incretin Mimetic : The First in a New Therapeutic Class in the Treatment of Diabetes | Semantic Scholar
DATA SHEET
Overview of clinical trials comparing liraglutide qd with exenatide... | Download Table
Efficacy and Safety of Exenatide versus Insulin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
Estimated average daily usage and cost of exenatide BiD and liraglutide... | Download Table
